Cardiovascular nuclear magnetic resonance: Basic and clinical applications

Journal of Clinical Investigation

Volumn 111, Issue 11, 2003, Pages 1630-1639

  Forder, John R ^a   Pohost, Gerald M ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOCARDIOGRAPHY; ANGIOGRAPHY; CARBON NUCLEAR MAGNETIC RESONANCE; CARDIOVASCULAR DISEASE; CONTRAST ENHANCEMENT; CORONARY ARTERY DISEASE; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; HEART MUSCLE ISCHEMIA; HEART MUSCLE PERFUSION; NUCLEAR MAGNETIC RESONANCE; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; REVIEW; SENSITIVITY AND SPECIFICITY; ANIMAL; CARDIOVASCULAR SYSTEM; HEART CONTRACTION; HEART MUSCLE; HUMAN; IMAGE PROCESSING; KINETICS; LIPID METABOLISM; METABOLISM; METHODOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; PERFUSION; SPECTROPHOTOMETRY;

OXYGEN;

ANGIOGRAPHY; ANIMALS; CARDIOVASCULAR SYSTEM; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; KINETICS; LIPID METABOLISM; MAGNETIC RESONANCE IMAGING; MAGNETIC RESONANCE SPECTROSCOPY; MYOCARDIAL CONTRACTION; MYOCARDIUM; OXYGEN; PERFUSION; SPECTROPHOTOMETRY;

EID: 0037804729     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI200318868     Document Type: Review

References (118)

1. Bloch, F. 1946. Nuclear induction. Physical Review (Physics). 70:460-473.
2. Purcell, E., Torrey, H., and Pound, R. 1946. Resonance adsorption by nuclear magnetic moments in a solid. Physical Review (Physics). 69:37-38.
3. Damadian, R.V. 1971. Tumor detection by nuclear magnetic resonance. Science. 171:1151-1153.
4. Lauterbur, P. 1973. Image formation by induced local interactions: examples employing nuclear magnetic resonance. Nature. 242:190-191.
5. Kumar, A., Welti, D., and Ernst, R.R. 1975. NMR Fourier zeugmatography. J. Magn. Reson. 18:69-83.
6. Damadian, R., Goldsmith, M., and Minkoff, L. 1977. NMR in cancer. XVI. FONAR image of the live human body. Physiol. Chem. Phys. 9:97-100.
7. Mansfield, P. 1977. Multi-planar image formation using NMR spin echoes. J. Phys. 10:L55-L58.
8. Jacobus, W.E., Taylor, G.J.T., Hollis, D.P., and Nunnally, R.L. 1977. Phosphorus nuclear magnetic resonance of perfused working rat hearts. Nature. 265:756-758.
9. Garlick, P.B., Radda, G.K., and Seeley, P.J. 1977. Phosphorus NMR studies on perfused heart. Biochem. Biophys. Res. Commun. 74:1256-1262.
10. Goldman, M.R., Pohost, G.M., Ingwall, J.S., and Fossel, E.T. 1980. Nuclear magnetic resonance imaging: potential cardiac applications. Am. J. Cardiol. 46:1278-1283.
11. Pohmann, R., von Kienlin, M., and Haase, A. 1997. Theoretical evaluation and comparison of fast chemical shift imaging methods. J. Magn. Reson. 129:145-160.
12. Kenn, W., Ochs, G., Pabst, T.A., and Hahn, D. 2001. 1H spectroscopy in patients with amyotrophic lateral sclerosis. J. Neuroimaging. 11:293-297.
13. Fischer, M., Bockhorst, K., Hoehn-Berlage, M., Schmitz, B., and Hossmann, K.A. 1995. Imaging of the apparent diffusion coefficient for the evaluation of cerebral metabolic recovery after cardiac arrest. Magn. Reson. Imaging. 13:781-790.
14. Axel, L., and Dougherty, L. 1989. MR imaging of motion with spatial modulation of magnetization. Radiology. 171:841-845.
15. Neubauer, S., Horn, M., Hahn, D., and Kochsiek, K. 1998. Clinical cardiac magnetic resonance spectroscopy: present state and future directions. Mol. Cell. Biochem. 184:439-443.
16. Schmidt, O., et al. 2000. Artifacts in CSI-measurements caused by the drift of the static magnetic field. MAGMA. 10:167-170.
17. Yabe, T., Mitsunami, K., and Inubushi, T. 1997. Clinical efficacy of three-dimensional chemical shift imaging (3D-CSI): a study of 3D-CSI in the human heart and its clinical perspectives for the future. Nippon Rinsho. 55:1839-1843.
18. Singer, J.R. 1986. Nuclear magnetic resonance blood flow measurements. Cardiovasc. Intervent. Radiol. 8:251-259.
19. Kim, R.J., Hillenbrand, H.B., and Judd, R.M. 2000. Evaluation of myocardial viability by MRI. Herz. 25:417-430.
20. Judd, R.M., et al. 1995. Physiological basis of myocardial contrast enhancement in fast magnetic resonance images of 2-day-old reperfused canine infarcts. Circulation. 92:1902-1910.
21. Kim, R.J., Chen, E.L., Lima, J.A., and Judd, R.M. 1996. Myocardial Gd-DTPA kinetics determine MRI contrast enhancement and reflect the extent and severity of myocardial injury after acute reperfused infarction. Circulation. 94:3318-3326.
22. Croisille, P., et al. 1999. Differentiation of viable and nonviable myocardium by the use of three-dimensional tagged MRI in 2-day-old reperfused canine infarcts. Circulation. 99:284-291.
23. Zerhouni, E.A., Parish, D.M., Rogers, W.J., Yang, A., and Shapiro, E.P. 1988. Human heart: tagging with MR imaging. A method for noninvasive assessment of myocardial motion. Radiology. 169:59-63.
24. Mosher, T.J., and Smith, M.B. 1990. A DANTE tagging sequence for the evaluation of translational sample motion. Magn. Reson. Med. 15:334-339.
25. Axel, L., and Dougherty, L. 1989. Heart wall motion: improved method of spatial modulation of magnetization for MR imaging. Radiology. 172:349-350.
26. Bolster, B.D., Jr., McVeigh, E.R., and Zerhouni, E.A. 1990. Myocardial tagging in polar coordinates with use of striped tags. Radiology. 177:769-772.
27. Bundy, J.M., and Lorenz, C.H. 1997. TAGASIST: a post-processing and analysis tools package for tagged magnetic resonance imaging. Comput. Med. Imaging Graph. 21:225-232.
28. Young, A.A. 1999. Model tags: direct three-dimensional tracking of heart wall motion from tagged magnetic resonance images. Med. Image Anal. 3:361-372.
29. Ryf, S., Spiegel, M.A., Gerber, M., and Boesiger, P. 2002. Myocardial tagging with 3D-CSPAMM. J. Magn. Reson. Imaging. 16:320-325.
30. Kondo, T., et al. 1992. Evaluation of cardiac motion and function by cine magnetic resonance imaging. Jpn. Circ. J. 56:632-638.
31. Croisille, P., Guttman, M.A., Atalar, E., McVeigh, E.R., and Zerhouni, E.A. 1998. Precision of myocardial contour estimation from tagged MR images with a "black-blood" technique. Acad. Radiol. 5:93-100.
32. Bazille, A., Guttman, M.A., McVeigh, E.R., and Zerhouni, E.A. 1994. Impact of semiautomated versus manual image segmentation errors on myocardial strain calculation by magnetic resonance tagging. Invest. Radiol. 29:427-433.
33. Pelc, L.R., et al. 1994. Evaluation of myocardial motion tracking with cine-phase contrast magnetic resonance imaging. Invest. Radiol. 29:1038-1042.
34. Pike, G.B., Meyer, C.H., Brosnan, T.J., and Pelc, N.J. 1994. Magnetic resonance velocity imaging using a fast spiral phase contrast sequence. Magn. Reson. Med. 32:476-483.
35. Drangova, M., Zhu, Y., Bowman, B., and Pelc, N.J. 1998. In vitro verification of myocardial motion tracking from phase-contrast velocity data. Magn. Reson. Imaging. 16:863-870.
36. Aletras, A.H., Ding, S., Balaban, R.S., and Wen, H. 1999. DENSE: displacement encoding with stimulated echoes in cardiac functional MRI. J. Magn. Reson. 137:247-252.
37. Wen, H. 2001. Mapping the velocity vector onto the spin vector: two-dimensional velocity-selective spin excitation for MR flow imaging. Magn. Reson. Med. 46:767-772.
38. Langerak, S.E., et al. 2002. Detection of vein graft disease using high-resolution magnetic resonance angiography. Circulation. 105:328-333.
39. Langerak, S.E., et al. 2001. Improved MR flow mapping in coronary artery bypass grafts during adenosine-induced stress. Radiology. 218:540-547.
40. Ishida, N., et al. 2001. Mr flow measurement in the internal mammary artery-to-coronary artery bypass graft: comparison with graft stenosis at radiographic angiography. Radiology. 220:441-447.
41. Kim, W.Y., et al. 2001. Coronary magnetic resonance angiography for the detection of coronary stenoses. N. Engl. J. Med. 345:1863-1869.
42. Choudhury, R.P., Fuster, V., Badimon, J.J., Fisher, E.A., and Fayad, Z.A. 2002. MRI and characterization of atherosclerotic plaque: emerging applications and molecular imaging. Arterioscler. Thromb. Vasc. Biol. 22:1065-1074.
43. Corti, R., Fuster, V., Badimon, J.J., Hutter, R., and Fayad, Z.A. 2001. New understanding of atherosclerosis (clinically and experimentally) with evolving MRI technology in vivo. Ann. N. Y. Acad. Sci. 947:181-195; discussion 195-198.
44. Spuentrup, E., et al. 2002. Magnetic resonance: guided coronary artery stent placement in a swine model. Circulation. 105:874-879.
45. Zenovich, A., Muehling, O.M., Panse, P.M., Jerosch-Herold, M., and Wilke, N. 2001. Magnetic resonance first-pass perfusion imaging: overview and perspectives. Rays. 26:53-60.
46. Doyle, M., et al. 2003. The impact of myocardial flow reserve on the detection of coronary artery disease by perfusion imaging methods: an NHLBI study. J. Cardiovasc. Magn. Reson. In press.
47. Weiss, R.G., Bottomley, P.A., Hardy, C.J., and Gerstenblith, G. 1990. Regional myocardial metabolism of high-energy phosphates during isometric exercise in patients with coronary artery disease. N. Engl. J. Med. 323:1593-1600.
48. 31P magnetic resonance spectroscopy during handgrip exercise. Circulation. 89:1709-1716.
49. Buchthal, S.D., et al. 2000. Abnormal myocardial phosphorus-31 nuclear magnetic resonance spectroscopy in women with chest pain but normal coronary angiograms. N. Engl. J. Med. 342:829-835.
50. Navon, G., Shinar, H., Eliav, U., and Seo, Y. 2001. Multiquantum filters and order in tissues. NMR Biomed. 14:112-132.
51. 23Na double quantum NMR. Biophys. J. 64:1273-1279.
52. 23Na in biological tissues. J. Magn. Reson. B. 103:19-29.
53. 23Na multiple-quantum-filtered NMR study of the effect of the cytoskeleton conformation on the anisotropic motion of sodium ions in red blood cells. J. Magn. Reson. B. 110:16-25.
54. Knubovets, T., Shinar, H., and Navon, G. 1998. Quantification of the contribution of extracellular sodium to 23Na multiple-quantum-filtered NMR spectra of suspensions of human red blood cells. J. Magn. Reson. 131:92-96.
55. Schepkin, V.D., et al. 1998. Sodium TQF NMR and intracellular sodium in isolated crystalloid perfused rat heart. Magn. Reson. Med. 39:557-563.
56. Askenasy, N., and Navon, G. 1998. Intracellular volumes and membrane permeability in rat hearts during prolonged hypothermic preservation with St. Thomas and University of Wisconsin solutions. J. Mol. Cell. Cardiol. 30:1329-1339.
57. Askenasy, N., Vivi, A., Tassini, M., and Navon, G. 1996. The relation between cellular sodium, pH and volumes and the activity of Na/H antiport during hypothermic ischemia: multinuclear NMR studies of rat hearts. J. Mol. Cell. Cardiol. 28:589-601.
58. Askenasy, N., Vivi, A., Tassini, M., Navon, G., and Farkas, D.L. 2001. NMR spectroscopic characterization of sarcolemmal permeability during myocardial ischemia and reperfusion. J. Mol. Cell. Cardiol. 33:1421-1433.
59. + exchange on intracellular sodium and pH in working and ischemic hearts. Magn. Reson. Med. 32:556-564.
60. 23Na NMR studies of myotonic dystrophy. Magn. Reson. Med. 37:192-196.
61. 23Na-MRI of the human heart using a 3D radial projection technique. Biomed. Tech. (Berl.) 47(Suppl. 1):458-459.
62. 23Na MR imaging: comparison with cine MR imaging and delayed contrast enhancement. Radiology. 221:222-228.
63. 23Na-NMR study. J. Appl. Physiol. 91:2695-2702.
64. 23Na MRI of the human heart. Magn. Reson. Med. 45:164-166.
65. 23Na-NMR study. Magn. Reson. Med. 45:756-764.
66. 23Na magnetic resonance image intensity to infarct size after acute reperfused myocardial infarction. Circulation. 100:185-192.
67. 23Na magnetic resonance imaging of acute reperfused myocardial infarction. Potential to assess myocardial viability. Circulation. 95:1877-1885.
68. Evanochko, W.T., Reeves, R.C., Sakai, T.T., Canby, R.C., and Pohost, G.M. 1987. Proton NMR spectroscopy in myocardial ischemic insult. Magn. Reson. Med. 5:23-31.
69. Reeves, R.C., Evanochko, W.T., Canby, R.C., McMillin, J.B., and Pohost, G.M. 1989. Demonstration of increased myocardial lipid with postischemic dysfunction ("myocardial stunning") by proton nuclear magnetic resonance spectroscopy. J. Am. Coll. Cardiol. 13:739-744.
70. Scollan, D.F., Holmes, A., Zhang, J., and Winslow, R.L. 2000. Reconstruction of cardiac ventricular geometry and fiber orientation using magnetic resonance imaging. Ann. Biomed. Eng. 28:934-944.
71. Hsu, E.W., and Henriquez, C.S. 2001. Myocardial fiber orientation mapping using reduced encoding diffusion tensor imaging. J. Cardiovasc. Magn. Reson. 3:339-347.
72. Hsu, E.W, Muzikant, A.L., Matulevicius, S.A., Penland, R.C., and Henriquez, C.S. 1998. Magnetic resonance myocardial fiber-orientation mapping with direct histological correlation. Am. J. Physiol. 274:H1627-H1634.
73. Scollan, D.F., Holmes, A., Winslow, R., and Forder, J. 1998. Histological validation of myocardial microstructure obtained from diffusion tensor magnetic resonance imaging. Am. J. Physiol. 275:H2308-H2318.
74. Forder, J.R., Bui, J.D., Buckley, D.L., and Blackband, S.J. 2001. MR imaging measurement of compartmental water diffusion in perfused heart slices. Am. J. Physiol. Heart Circ. Physiol. 281:H1280-H1285.
75. Hsu, E.W., Buckley, D.L., Bui, J.D., Blackband, S.J., and Forder, J.R. 2001. Two-component diffusion tensor MRI of isolated perfused hearts. Magn. Reson. Med. 45:1039-1045.
76. Hsu, E.W., Xue, R., Holmes, A., and Forder J.R. 1998. Delayed reduction of tissue water diffusion after myocardial ischemia. Am. J. Physiol. 275:H697-H702.
77. Dou, J., Reese, T.G., Tseng, W.Y., and Wedeen, V.J. 2002. Cardiac diffusion MRI without motion effects. Magn. Reson. Med. 48:105-114.
78. Tseng, W.Y., Reese, T.G., Weisskoff, R.M., Brady, T.J., and Wedeen, V.J. 2000. Myocardial fiber shortening in humans: initial results of MR imaging. Radiology. 216:128-139.
79. Tseng, W.Y., Reese, T.G., Weisskoff, R.M., and Wedeen, V.J. 1999. Cardiac diffusion tensor MRI in vivo without strain correction. Magn. Reson. Med. 42:393-403.
80. Reese, T.G., et al. 1995. Imaging myocardial fiber architecture in vivo with magnetic resonance. Magn. Reson. Med. 34:786-791.
81. Flacke, S., et al. 2001. Novel MRI contrast agent for molecular imaging of fibrin: implications for detecting vulnerable plaques. Circulation. 104:1280-1285.
82. Lanza, G.M., et al. 2002. Molecular imaging and targeted drug delivery with a novel, ligand-directed paramagnetic nanoparticle technology. Acad. Radiol. 9(Suppl. 2):S330-S331.
83. Wickline, S.A., and Lanza, G.M. 2002. Molecular imaging, targeted therapeutics, and nanoscience. J. Cell. Biochem. Suppl. 39:90-97.
84. Wickline, S.A., and Lanza, G.M. 2003. Nanotechnology for molecular imaging and targeted therapy. Circulation. 107:1092-1095.
85. Mason, R.P., Jeffrey, F.M., Malloy, C.R., Babcock, E.E., and Antich, P.P. 1992. A noninvasive assessment of myocardial oxygen tension: 19F NMR spectroscopy of sequestered perfluorocarbon emulsion. Magn. Reson. Med. 27:310-317.
86. Vink, R. 1992. Nuclear magnetic resonance spectroscopy and the study of tissue oxygen metabolism: a review. Adv. Exp. Med. Biol. 316:187-193.
87. Arai, T., et al. 1991. In vivo oxygen-17 nuclear magnetic resonance for the estimation of cerebral blood flow and oxygen consumption. Biochem. Biophys. Res. Commun. 179:954-961.
88. Pekar, J., et al. 1991. In vivo measurement of cerebral oxygen consumption and blood flow using 17O magnetic resonance imaging. Magn. Reson. Med. 21:313-319.
89. Fiat, D., et al. 1992. In vivo 17O NMR study of rat brain during 17O2 inhalation. Magn. Reson. Med. 24:370-374.
90. Zhu, X.H., Merkle, H., Kwag, J.H., Ugurbil, K., and Chen, W. 2001. 17O relaxation time and NMR sensitivity of cerebral water and their field dependence. Magn. Reson. Med. 45:543-549.
91. Zhu, X.H., et al. 2002. Development of (17)O NMR approach for fast imaging of cerebral metabolic rate of oxygen in rat brain at high field. Proc. Natl. Acad. Sci. U. S. A 99:13194-13199.
92. Mateescu, G.D. 2003. Functional oxygen-17 magnetic resonance imaging and localized spectroscopy. Adv. Exp. Med. Biol. 510:213-218.
93. Li, D., Dhawale, P., Rubin, P.J., Haacke, E.M., and Gropler, R.J. 1996. Myocardial signal response to dipyridamole and dobutamine: demonstration of the BOLD effect using a double-echo gradient-echo sequence. Magn. Reson. Med. 36:16-20.
94. Wacker, C.M., et al. 1999. Changes in myocardial oxygenation and perfusion under pharmacological stress with dipyridamole: assessment using T*2 and T1 measurements. Magn. Reson. Med. 41:686-695.
95. Reeder, S.B., Holmes, A.A., McVeigh, E.R., and Forder, J.R. 1999. Simultaneous noninvasive determination of regional myocardial perfusion and oxygen content in rabbits: toward direct measurement of myocardial oxygen consumption at MR imaging. Radiology. 212:739-747.
96. Niemi, P., et al. 1996. Myocardial intensity changes associated with flow stimulation in blood oxygenation sensitive magnetic resonance imaging. Magn. Reson. Med. 36:78-82.
97. Atalay, M.K., Forder, J.R., Chacko, V.P., Kawamoto, S., and Zerhouni, E.A. 1993. Oxygenation in the rabbit myocardium: assessment with susceptibility-dependent MR imaging. Radiology. 189:759-764.
98. Pluim, B.M., et al. 1998. Functional and metabolic evaluation of the athlete's heart by magnetic resonance imaging and dobutamine stress magnetic resonance spectroscopy. Circulation. 97:666-672.
99. Chatham, J.C., Forder, J.R., Glickson, J.D., and Chance, E.M. 1995. Calculation of absolute metabolic flux and the elucidation of the pathways of glutamate labeling in perfused rat heart by 13C NMR spectroscopy and nonlinear least squares analysis. J. Biol. Chem. 270:7999-8008.
100. Weiss, R.G. 1998. 13C-NMR for the study of intermediary metabolism. MAGMA. 6:132.
101. Weiss, R.G., et al. 1992. Indexing tricarboxylic acid cycle flux in intact hearts by carbon-13 nuclear magnetic resonance. Circ. Res. 70:392-408.
102. 13C NMR spectroscopy. FEBS Lett. 212:58-62.
103. Weiss, R.G., Chacko, V.P., Glickson, J.D., and Gerstenblith, G. 1989. Comparative 13C and 31P NMR assessment of altered metabolism during graded reductions in coronary flow in intact rat hearts. Proc. Natl. Acad. Sci. U. S. A. 86:6426-6430.
104. Reeder, S.B., Atalay, M.K., McVeigh, E.R., Zerhouni, E.A., and Forder, J.R. 1996. Quantitative cardiac perfusion: a noninvasive spin-labeling method that exploits coronary vessel geometry. Radiology. 200:177-184.
105. Pohost, G.M., Meduri, A., Razmi, R.M., Rathi, V.K., and Doyle, M. 2001. Cardiac MR spectroscopy in the new millennium. Rays. 26:93-107.
106. Mahrholdt, H., et al. 2002. Reproducibility of chronic infarct size measurement by contrast-enhanced magnetic resonance imaging. Circulation. 106:2322-2327.
107. Bottomley, P.A. 1985. Noninvasive study of high-energy phosphate metabolism in human heart by depth-resolved 31P NMR spectroscopy. Science. 229:769-772.
108. Bottomley, P.A. 1987. Spatial localization in NMR spectroscopy in vivo. Ann. N. Y. Acad. Sci. 508:333-348.
109. Hardy, C.J., Weiss, R.G., Bottomley, P.A., and Gerstenblith, G. 1991. Altered myocardial high-energy phosphate metabolites in patients with dilated cardiomyopathy. Am. Heart J. 122:795-801.
110. Bottomley, P.A., Weiss, R.G., Hardy, C.J., and Baumgartner, W.A. 1991. Myocardial high-energy phosphate metabolism and allograft rejection in patients with heart transplants. Radiology. 181:67-75.
111. Schaefer, S., et al. 1988. Nuclear magnetic resonance imaging-guided phosphorus-31 spectroscopy of the human heart. J. Am. Coll. Cardiol. 12:1449-1455.
112. Luyten, P.R., Groen, J.P., Vermeulen, J.W., and den Hollander, J.A. 1989. Experimental approaches to image localized human 31P NMR spectroscopy. Magn. Reson. Med. 11:1-21.
113. Twieg, D.B., et al. 1989. Phosphorus-31 magnetic resonance spectroscopy in humans by spectroscopic imaging: localized spectroscopy and metabolite imaging. Magn. Reson. Med. 12:291-305.
114. Moonen, C.T., et al. 1989. Comparison of single-shot localization methods (STEAM and PRESS) for in vivo proton NMR spectroscopy. NMR Biomed. 2:201-208.
115. Turner, R., von Kienlin, M., Moonen, C.T., and van Zijl, P.C. 1990. Single-shot localized echo-planar imaging (STEAM-EPI) at 4.7 tesla. Magn. Reson. Med. 14:401-408.
116. Pohmann, R., Rommel, E., and von Kienlin, M. 1999. Beyond k-space: spectral localization using higher order gradients. J. Magn. Reson. 141:197-206.
117. von Kienlin, M., et al. 2001. Advances in human cardiac 31P-MR spectroscopy: SLOOP and clinical applications. J. Magn. Reson. Imaging. 13:521-527.
118. Loffler, R., Sauter, R., Kolem, H., Haase, A., and von Kienlin, M. 1998. Localized spectroscopy from anatomically matched compartments: improved sensitivity and localization for cardiac 31P MRS in humans. J. Magn. Reson. 134:287-299.